A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
| Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
| C155 | C155 Cortison | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C1INHF | C1-INH funkt. | % | 70.0 | - | 130.0 | MATERIAL: Citrat+Serum |
| C1INHQ | C1-INH quant. | g/l | 0.210 | - | 0.380 | MATERIAL: Citrat+Serum |
| C1 | C1 Penicillin G | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C209 | C209 Chymopapain | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C227 | C227 Paracetamol | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C24_C22_R | C24/C22 Ratio | < | 1.000 | MATERIAL: Serum; METHODE: Calc. | ||
| C26_C22_R | C26/C22 Ratio | < | 0.020 | MATERIAL: Serum; METHODE: Calc. | ||
| C2 | C2 Penicillin V | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C5 | C5 Ampicillin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C6 | C6 Amoxycillin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C70 | C70 Insulin Schwein | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C71 | C71 Insulin Rind | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C73 | C73 Insulin Human | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C74 | C74 Gelatine (Schwein) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| C7 | C7 Cefaclor | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| CA125 | CA 125 | U/ml | 0.0 | - | 35.0 | MATERIAL: Serum, METHODE: MEIA |
| CA15-3 | CA 15-3 | U/ml | 0.0 | - | 35.0 | MATERIAL: Serum, METHODE: MEIA |
| CA19-9 | CA 19-9 | U/ml | 0.0 | - | 37.0 | MATERIAL: Serum, METHODE: CMIA |
| CA50 | CA 50 | U/ml | < | 25.00 | MATERIAL: Serum Methode: RIA | |
| CA72-4 | CA 72-4 | U/ml | 0.00 | - | 6.90 | MATERIAL: Serum, METHODE: EIA |
| CDUKR | Cadmium /g Krea i.H. | ug/g Krea | 0.000 | - | 2.500 | MATERIAL: Spontanharn, METHODE: |
| CDU | Cadmium i.H. | ug/l | 0.000 | - | 0.800 | MATERIAL: Spontanharn, METHODE: AAS |
| CDH | Cadmium im 24h H. | ug/24h | 0.000 | - | 2.250 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
| CDV | Cadmium im Vollblut (EDTA) | ug/dl | 0.000 | - | 0.100 | MATERIAL: EDTA, METHODE: AAS |
| VGCCAKN | Ca-Kanal(VGCC)-AK (N-Typ) | Ak-RATIO | 0.000 | - | 15.000 | MATERIAL: Serum, Methode: RIA |
| VGCCAKPQ | Ca-Kanal(VGCC)-AK (P/Q-Typ) | pmol/l | 0.0 | - | 30.0 | MATERIAL: Serum, Methode: RIA |
| CALC | Calcitonin | pg/ml | 0.000 | - | 9.520 | MATERIAL: Serum, METHODE: EIA |
| CA | Calcium | mmol/l | 2.100 | - | 2.600 | MATERIAL: Serum, METHODE: photometrisch |
| CAH | Calcium i.24h H. | mmol/24h | 2.500 | - | 7.500 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
| CAV | Calcium i.Vollblut | mg/dl | 4.600 | - | 6.600 | MATERIAL: EDTA, METHODE: AAS |
| CAION | Calcium ionisiert (berechnet) | mmol/l | 2.100 | - | 2.600 | MATERIAL: Serum/Vollblut, METHODE:photometrisch |
| CAKREAQ | Calcium Kreatinin Ratio | mmol/mmol | 0.000 | - | 0.570 | |
| CALPROTS | Calprotectin | ug/l | 0.00 | - | 3000.00 | MATERIAL: Serum, |
| CALPROTST | Calprotectin i.St. | mg/kg | 0.00 | - | 50.00 | MATERIAL: Stuhl, METHODE: ELISA |
| CALRETEX9 | Calreticulin Ex9 Mutation | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
| CAMP | Campylobakter | - | MATERIAL: Serum/Vollblut, METHODE: KBR | |||
| CAMPAG | Campylobakter Erregernachweis | - | MATERIAL: Stuhl, | |||
| CAMPA | Campylobakter IgA | U/ml | 0.00 | - | 24.00 | MATERIAL: Serum, METHODE: ELISA |
| CAMPG | Campylobakter IgG | U/ml | 0.00 | - | 24.00 | MATERIAL: Serum, METHODE: ELISA |
| CAMPKULT | Campylobakter Kultur | - | MATERIAL: Stuhl, METHODE: Kultur | |||
| CANDAG | Candida Antigen im Serum | - | MATERIAL: Serum, METHODE: Agglutination | |||
| CANDA | Candida IgA | IU/ml | 0.000 | - | 80.000 | MATERIAL: Serum, METHODE: ELISA |
| CANDG | Candida IgG | IU/ml | 0.000 | - | 100.000 | MATERIAL: Serum, METHODE: ELISA |
| CANDM | Candida IgM | IU/ml | 0.000 | - | 80.000 | MATERIAL: Serum, METHODE: ELISA |
| ABCAND | Candida im Abstrich | - | MATERIAL: Abstrich, METHODE: Kultur | |||
| CANS | Cannabinoide (S) | ug/l | 0.00 | - | 10.00 | MATERIAL: Serum, METHODE: FPIA |
| CANH | Cannabinoide i.H. | ng/ml | 0.0 | - | 50.0 | MATERIAL: Spontanharn, METHODE: EMIT |
| CARBA | Carbamazepin | ug/ml | 4.00 | - | 12.00 | MATERIAL: Serum, METHODE: FPIA |
| CAH_I_Ak | Carboanhydrase I Ak | - | MATERIAL: Serum, METHODE: EIA | |||
| CAH_II_Ak | Carboanhydrase II Ak | - | MATERIAL: Serum, METHODE: EIA | |||
| ACLAA | Cardiolipin-AK IgA | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: ELISA |
| ACLAG | Cardiolipin-AK IgG | U/ml | 0.00 | - | 12.00 | MATERIAL: Serum, METHODE: ELISA |
| ACLAM | Cardiolipin-AK IgM | U/ml | 0.00 | - | 12.00 | MATERIAL: Serum, METHODE: ELISA |
| CARIPRAZIN | Cariprazin | ug/l | 10.00 | - | 20.00 | MATERIAL: Serum, METHODE: LC-MS |
| CARN | Carnitin (freies) | mg/l | 4.00 | - | 9.80 | MATERIAL: Serum, METHODE: MS |
| COMP | Cartilage Olig.Matrix Protein | U/l | 0.0 | - | 15.0 | MATERIAL: Serum, METHODE: EIA |
| CASPR2AK | CASPR2-AK (IgG) | Titer | 0.00 | - | 10.00 | MATERIAL: Serum, Methode: IFT |
| ASPAGBEURT | Cave Asp.-AG (Galaktomannan): | - | MATERIAL: Serum, METHODE: ELISA | |||
| CDT | CDT-IFCC | % | 0.00 | - | 2.00 | MATERIAL: Serum, METHODE: HPLC |
| CEA | CEA | ng/ml | 0.00 | - | 3.00 | MATERIAL: Serum, METHODE: CMIA |
| CENOBAMAT | Cenobamat | mg/l | 5.00 | - | 35.00 | MATERIAL: 2xSerum; METHODE: LC-MS |
| ACA | Centromer AK | - | MATERIAL: Serum; METHODE: IFT/Blot | |||
| CENPB | Centromer AK (quantitativ) | EliAU/ml | 0.00 | - | 6.90 | MATERIAL: Serum, METHODE: |
| CEROTINSRE | Cerotinsäure C26:0 | umol/l | 0.20 | - | 1.60 | MATERIAL: Serum Methode: GC-MS |
| CH50 | CH-50 | U/ml | 32.0 | - | 58.0 | MATERIAL: Serum, METHODE: turbidimetrisch |
| CHLPNEUPCR | Chl.pneumoniae DNA (PCR) | - | MATERIAL: Abstrich/Sputum/Punktat, METHODE: PCR | |||
| CHL_L1-L3 | Chl.trach. DNA L1-L3 | - | MATERIAL: Abstrich, METHODE: PCR | |||
| CHL_L1-L3H | Chl.trach. DNA L1-L3 i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
| CHL_ompA | Chl.trach. DNA ompA Gen | - | MATERIAL: Abstrich, METHODE: PCR | |||
| CHL_ompAH | Chl.trach. DNA ompA Gen i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
| CHLTRPCRU | Chl.trach.PCR i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
| CHLTRPCR | Chl.trachomatis DNA (PCR) | - | MATERIAL: Serum/Sputum/Punktat, METHODE: PCR | |||
| CHLPNEUA | Chlamydia pneumoniae IgA | U/ml | 0.00 | - | 25.00 | MATERIAL: Serum, METHODE: Immunfluoreszenz |
| CHLPNEUG | Chlamydia pneumoniae IgG | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
| CHLPNEUM | Chlamydia pneumoniae IgM | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
| CHLPSIT | Chlamydia psittaci (KBR) | 0.0 | - | 19.9 | MATERIAL: Serum, METHODE: KBR | |
| CHLPSITA | Chlamydia psittaci IgA | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT | |
| CHLPSITG | Chlamydia psittaci IgG | 0.0 | - | 100.0 | MATERIAL: Serum, METHODE: IFT | |
| CHLPSITM | Chlamydia psittaci IgM | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT | |
| CHLTRPCRAB | Chlamydia trach.(PCR) i.Abstr. | - | MATERIAL: Abstrich, METHODE: PCR | |||
| CHLTRACHA | Chlamydia trachomatis IgA | - | MATERIAL: Serum, METHODE: ELISA | |||
| CHLTRACHG | Chlamydia trachomatis IgG | - | MATERIAL: Serum, METHODE: ELISA | |||
| CL | Chlorid | mmol/l | 95.0 | - | 110.0 | MATERIAL: Serum, METHODE: ISE |
| CLH | Chlorid i.24h H. | mmol/24h | 2.0 | - | 250.0 | MATERIAL: 24h-Sammelharn, METHODE: ISE |
| CHLORPROT | Chlorprothixen | ng/ml | 20.00 | - | 300.00 | MATERIAL: Serum, METHODE: LC-MS |
| CHOL | Cholesterin | mg/dl | < | 200.0 | MATERIAL: Serum, METHODE: photometrisch | |
| CHOLRAT | Cholesterin-Ratio | - | ||||
| CHE | Cholinesterase | kU/l | 2.90 | - | 12.90 | MATERIAL: Serum, METHODE: photometrisch |
| CRH | Chrom i.24h H. | ug/24h | 0.00 | - | 0.90 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
| CRU | Chrom i.H. | ug/l | 0.000 | - | 0.600 | MATERIAL: Spontanharn, METHODE: AAS |
| CR | Chrom im Serum | ug/l | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: AAS |
| CRV | Chrom im Vollblut (EDTA) | ug/l | 0.500 | - | 4.000 | MATERIAL: EDTA, METHODE: AAS |
| CGA | Chromogranin A | ug/l | 0.00 | - | 100.00 | MATERIAL: Serum, Methode: LIA (TRIF) |
| CIC1Q | CIC-C1q-IgG | ug/ml | 0.0 | - | 45.0 | MATERIAL: Serum/Vollblut, METHODE: ID |
| CIC3D | CIC-C3d-IgG | ug/ml | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
| CITALO | Citalopram | ng/ml | 50.00 | - | 110.00 | MATERIAL: Serum, METHODE: HPLC |
| CITRATH | Citrat im 24h H. | mg/24h | 300.00 | - | 860.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: GC-MS |
| CITRULLINU | Citrullin /mol Krea i.H. | mmol/mol Kreat | 0.00 | - | 4.00 | MATERIAL: 2.Morgenharn, Methode: LC-MS |
| CK | CK | U/l | 29.00 | - | 200.00 | MATERIAL: Serum, METHODE: photometrisch |
| CKBB-E | CK-BB | % | - | MATERIAL: Serum, METHODE: ELPHOR | ||
| CKELPHOR | CK-Isoenzym-Elektrophorese | - | MATERIAL: Serum/Vollblut | |||
| CKMB-E | CK-MB | % | 0.00 | - | 3.00 | MATERIAL: Serum, METHODE: ELPHOR |
| CKMB | CK-MB | U/l | 0.0 | - | 24.0 | MATERIAL: Serum, METHODE: photometrisch |
| CKMB% | CK-MB relativ | % | - | MATERIAL: Serum/Vollblut, METHODE: GC/MS | ||
| CKMM-E | CK-MM | % | 97.00 | - | 100.00 | MATERIAL: Serum, METHODE: ELPHOR |
| CLINDA | Clindamycin | mg/l | - | MATERIAL: Serum, METHODE: | ||
| CLOBA | Clobazam | ug/l | 30.00 | - | 300.00 | MATERIAL: Serum, METHODE: LC-MS/MS |
| CLOMI_GES | Clomipramin + Norclomipramin | ng/ml | 230.00 | - | 450.00 | |
| CLONA | Clonazepam | ug/l | 10.00 | - | 80.00 | MATERIAL: Serum, METHODE: LC-MS |
| CLOS | Clos.diff.Toxinnachweis i.St. | - | MATERIAL: Stuhl, | |||
| CLOZ | Clozapin | ng/ml | 350.00 | - | 600.00 | MATERIAL: Serum, METHODE: LC-MS |
| CLOZDESME | Clozapin (Desmethyl-) | ng/ml | - | MATERIAL: Serum, METHODE: LC-MS | ||
| CLNORQ_STA | Clozapin-Norclozapin-Quotient | 1.000 | - | 2.500 | ||
| CLOZNOXID | Clozapin-N-Oxid | ng/ml | 15.00 | - | 140.00 | MATERIAL: Serum, METHODE: LC-MS |
| CMV | CMV IgG | - | MATERIAL: Serum, METHODE: ELFA | |||
| CMVM | CMV IgM | - | MATERIAL: Serum, METHODE: ELFA | |||
| CMVPCR | CMV-Virus DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
| COUKR | Cobalt /g Krea i.H. | ug/g Krea | - | MATERIAL: Spontanharn, METHODE: AAS/Clia | ||
| COU | Cobalt i.H. | ug/l | 0.00 | - | 1.00 | MATERIAL: Spontanharn, METHODE: AAS |
| COH | Cobalt im 24h H. | ug/24h | 0.00 | - | 1.50 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
| CO | Cobalt im Serum | ug/l | 0.00 | - | 0.60 | MATERIAL: Serum/Vollblut, METHODE: ICP-MS |
| COCS | Cocain (S) | - | MATERIAL: Serum, METHODE: FPIA | |||
| COCH | Cocainmetabolite i.H. | ng/ml | 0.0 | - | 300.0 | MATERIAL: Spontanharn, METHODE: EMIT |
| COERU | Coeruloplasmin | mg/dl | 15.00 | - | 45.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
| COFF | Coffein (S) | ug/ml | 5.000 | - | 20.000 | MATERIAL: Serum, METHODE: HPLC |
| C2_comp | Complement C2 | mg/dl | 14.00 | - | 25.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
| C3_comp | Complement C3 | mg/dl | 90.00 | - | 180.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
| C4_comp | Complement C4 | mg/dl | 10.00 | - | 40.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
| DCT | Coombstest direkt | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
| CORT | Cortisol | ug/dl | 4.80 | - | 19.50 | MATERIAL: Serum, METHODE: LIA |
| CORTH | Cortisol i.24h H. | ug/24h | 11.50 | - | 102.00 | MATERIAL: 24h-Sammelharn, METHODE: LIA |
| CORT_SP | Cortisol im Speichel | ug/dl | 0.0000 | - | 0.8740 | MATERIAL: Speichel, METHODE: ECLIA |
| COTS | Cotinin | µg/l | 0.0 | - | 10.0 | MATERIAL: Serum, |
| COTU | Cotinin i.H. | ng/ml | 0.0 | - | 20.0 | MATERIAL: Spontanharn, |
| COVMAB | COVID19 IgM-Ak | - | MATERIAL: Serum, METHODE: CMIA | |||
| COVNUKAB | COVID19 N-Kapsid AK (Roche) | - | MATERIAL: Serum, METHODE: immunologisch | |||
| CPEP | C-Peptid | ng/ml | 1.10 | - | 4.40 | MATERIAL: Serum, METHODE: LIA |
| CRP | CRP | mg/dl | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: turbidimetrisch |
| CRPP | CRP im Punktat | mg/dl | - | MATERIAL: Punktat, METHODE: turbidimetrisch | ||
| CRYPTOST | Cryptosporidien i.St. | - | MATERIAL: Stuhl, | |||
| COPA | CT-proAVP (Copeptin) | pmol/l | - | MATERIAL: Serum/Vollblut | ||
| CTX_V | CTX (ß-Crosslaps) | ng/ml | 0.000 | - | 1.000 | MATERIAL: Serum, Methode: ECLID |
| CTX | CTX (ß-Crosslaps) | ng/l | 118.0 | - | 1060.0 | MATERIAL: Serum, Methode: ECLID |
| CCPAK | Cycl. Citrullin Peptid-AK | U/ml | 0.000 | - | 5.000 | MATERIAL: Serum, Methode: EIA |
| CYCLO | Cyclosporin A monokl. | ug/l | - | MATERIAL: EDTA, METHODE: FPIA | ||
| CYFRA | CYFRA 21-1 | ng/ml | 0.000 | - | 2.370 | MATERIAL: Serum, METHODE: TRACE |
| CYPP450 | CYP P450 | - | MATERIAL: EDTA (5ml), Methode: Gentest | |||
| CYSTATU | Cystathionin i.H. | ug/l | 80.00 | - | 11000.00 | MATERIAL: 2.Morgenharn, Methode: LC-MS |
| CYSC | Cystatin C | mg/l | 0.590 | - | 1.380 | MATERIAL: Serum, Methode: Immunturbidimetrie |
| CMVAVID | Cytomegalie IgG Avidität | - | MATERIAL: Serum, | |||
| CMVKBR | Cytomegalie KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum, METHODE: KBR |
| CYTABS | Cytotoxische Zellen absolut | /mm3 | 0.0 | - | 70.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
| CYTREL | Cytotoxische Zellen relativ | % | 0.0 | - | 3.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |